» Articles » PMID: 36347210

The Modulatory Effects of Two Bioflavonoids, Quercetin and Thymoquinone on the Expression Levels of DNA Damage and Repair Genes in Human Breast, Lung and Prostate Cancer Cell Lines

Overview
Specialty Pathology
Date 2022 Nov 8
PMID 36347210
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The recent decade has witnessed the increasing potential of various flavonoids such as quercetin and thymoquinone in inhibiting cancer cells proliferation and growth and their therapeutic effects in various cancers. Therefore, in the current study, we aim to evaluate the expression levels of key factors of DNA damage response in human breast, lung and prostate cancer cell lines in response to treatment with quercetin and thymoquinone.

Methods: MTT assay was applied to assess the effects of quercetin and thymoquinone on the viability of MCF-7, A549, and PC3 cancer cells. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was used to evaluate the expression levels of p53, RAD51, Ku70, XRCC1, and H2AX in treated cells. In addition, the expression rate of 8-hydroxy-deoxyguanosine (8-OH-dG) was assessed by ELISA kit.

Results: The quercetin and thymoquinone induce cytotoxicity in breast, lung, and prostate cancer cells effectively; MCF-7 cells were the most sensitive cells to quercetin with an IC50 value of 50 μM and PC3 cells were more sensitive to thymoquinone with an IC50 value of 20 μM. The expression levels of DNA damage markers, H2AX, and 8-OH-dG were significantly increased in all cancer cells treated with quercetin and thymoquinone (p < 0.05). Moreover, both flavonoids significantly decreased the expression levels of DNA repair mediators, RAD51, Ku70, XRCC1, in cell lines. P53 was also increased in MCF-7 and A549 cells.

Conclusion: We concluded that quercetin and thymoquinone may exert their effects through modulation of DNA damage response, increasing DNA damage, and suppressing DNA repair genes.

Citing Articles

Exploring potential additive effects of 5-fluorouracil, thymoquinone, and coenzyme Q10 triple therapy on colon cancer cells in relation to glycolysis and redox status modulation.

Aslam A, Minshawi F, Almasmoum H, Almaimani R, Alsaegh A, Mahbub A J Egypt Natl Canc Inst. 2025; 37(1):7.

PMID: 40059278 DOI: 10.1186/s43046-025-00261-7.


Prominent Naturally Derived Oxidative-Stress-Targeting Drugs and Their Applications in Cancer Treatment.

Lee E, Yang D, Hong J Antioxidants (Basel). 2025; 14(1).

PMID: 39857383 PMC: 11760868. DOI: 10.3390/antiox14010049.


From nature to clinic: Quercetin's role in breast cancer immunomodulation.

Fang L, Gao D, Wang T, Zhao H, Zhang Y, Wang S Front Immunol. 2024; 15:1483459.

PMID: 39712006 PMC: 11659267. DOI: 10.3389/fimmu.2024.1483459.


Therapeutic Efficacy of Quercetin and Its Nanoformulation Both the Mono- or Combination Therapies in the Management of Cancer: An Update with Molecular Mechanisms.

Eity T, Bhuia M, Chowdhury R, Ahmmed S, Sheikh S, Akter R J Trop Med. 2024; 2024:5594462.

PMID: 39380577 PMC: 11461079. DOI: 10.1155/2024/5594462.


Quercetin in Oncology: A Phytochemical with Immense Therapeutic Potential.

Kamal R, Paul P, Thakur S, Singh S, Awasthi A Curr Drug Targets. 2024; 25(11):740-751.

PMID: 38988154 DOI: 10.2174/0113894501292466240627050638.